Latest Commercialization News

Everlast Minerals advances pilot operations at its Gaibandha Mineral Sands Project, securing a critical 500kW power connection and strengthening government ties in Bangladesh.

OM Holdings has fulfilled all conditions to sell its 26% stake in Ntsimbintle Mining to Exxaro Resources for approximately US$101.4 million, setting the stage for transaction completion by late February 2026.

OM Holdings has announced that the sale of its 26% interest in Ntsimbintle Mining is now unconditional, paving the way for completion by late February 2026.

Decidr AI Industries has solidified its position in the agentic AI market by completing strategic acquisitions and launching its DecidrOS platform, achieving a 60% revenue increase in the December quarter.

Liberty Metals has completed the acquisition of a 100% interest in a suite of Brazilian critical minerals projects, marking a significant strategic expansion into titanium and rare earth elements. The company also rebranded and initiated exploration programs to unlock value in these high-potential assets.

Piche Resources has launched its first reverse circulation drilling campaign at the Cerro Chacón Gold-Silver Project in Argentina, backed by a successful A$2 million capital raise and a strategic confidentiality agreement with a US nuclear utility.

NuEnergy Gas Limited reported a cash outflow in Q4 2025 but secured a binding gas sales agreement and a strategic funding collaboration to advance its Indonesian coal bed methane projects.

NuEnergy Gas Limited has completed drilling four wells at its Tanjung Enim project, gearing up for initial gas sales in the first half of FY26. The company also inked key agreements to finance and expand its coal bed methane operations in Indonesia.

Orbital Corporation Ltd reports a stronger cash position and a strategic new order for its 350cc heavy fuel engine, signalling growth in both military and commercial UAV markets.

Lumos Diagnostics reported a strong surge in FebriDx® sales alongside positive FDA feedback, securing full Medicare reimbursement and advancing key clinical studies.

Aeris Environmental Ltd has reported strong commercial momentum with its Syncromesh IoT platform and specialty chemicals, highlighted by initial orders from Budweiser APAC and a growing purchase order pipeline exceeding $800,000.

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.